(Q33784038)

29 July 2017

Targeting impulsivity in Parkinson's disease using atomoxetine (English)

1 reference

29 July 2017

1 reference

1 reference

6

1 reference

29 July 2017

Ralf Regenthal

3

0 references

Barbara J. Sahakian

Barbara J Sahakian

7

0 references

Roger A. Barker

Roger A Barker

4

0 references

Trevor W. Robbins

Trevor W Robbins

8

0 references

Charlotte R Housden

2

Charlotte R Housden

1 reference

29 July 2017

1

Angie A Kehagia

1 reference

29 July 2017

Ulrich Müller

5

1 reference

PubMed ID

24893708

29 July 2017

language of work or name

English

0 references

publication date

3 June 2014

1 reference

29 July 2017

1 reference

29 July 2017

137

1 reference

29 July 2017

Pt 7

1 reference

29 July 2017

1986-1997

1 reference

A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Noradrenergic modulation of cognition: therapeutic implications

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Deep brain stimulation of the subthalamic nucleus, but not dopaminergic medication, improves proactive inhibitory control of movement initiation in Parkinson's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

The challenge of non-motor symptoms in Parkinson's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Serotonin selectively influences moral judgment and behavior through effects on harm aversion

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Stimulation of the subthalamic nucleus and impulsivity: release your horses

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

A timeline for Parkinson's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

The neuropsychopharmacology of fronto-executive function: monoaminergic modulation

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Use of antidepressants and the risk of Parkinson's disease: a prospective study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Functional role of the supplementary and pre-supplementary motor areas

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Models of response inhibition in the stop-signal and stop-change paradigms

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

The effect of Parkinson's disease on interference control during action selection.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Inhibitory control is slowed in patients with right superior medial frontal damage

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Association of dopamine agonist use with impulse control disorders in Parkinson disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Neurochemical modulation of response inhibition and probabilistic learning in humans

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Clinical pharmacokinetics of atomoxetine

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Activation of conflicting responses in Parkinson's disease: evidence for degrading and facilitating effects on response time

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Inhibition of ongoing responses in patients with Parkinson's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

An Inventory for Measuring Depression

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Investigation of supervisory attentional system functions in patients with Parkinson's disease using the Hayling task

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Inhibition of ongoing responses following frontal, nonfrontal, and basal ganglia lesions.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Inhibition of subliminally primed responses is mediated by the caudate and thalamus: evidence from functional MRI and Huntington's disease.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Pathoanatomy of Parkinson's disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

4 July 2018

Varieties of impulsivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Effects of methylphenidate on spatial working memory and planning in healthy young adults.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Nigral and extranigral pathology in Parkinson's disease.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Slowed central processing in simple and go/no-go reaction time tasks in Parkinson's disease.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

On the ability to inhibit simple and choice reaction time responses: A model and a method

4 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

4 July 2018

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. An experimental study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Factor analysis of analogue scales measuring subjective feelings before and after sleep.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Central Catecholamine Neuron Systems: Anatomy and Physiology of the Norepinephrine and Epinephrine Systems

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

The subthalamic nucleus is involved in successful inhibition in the stop-signal task: a local field potential study in Parkinson's disease.

4 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Effects of methylphenidate on cognitive function and gait in patients with Parkinson's disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Functional brain changes in early Parkinson's disease during motor response and motor inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Horse-race model simulations of the stop-signal procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Response inhibition subprocesses and dopaminergic pathways: basal ganglia disease effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Methylphenidate treats apathy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Reflection impulsivity in current and former substance users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Mechanisms of cognitive set flexibility in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Clonidine and diazepam have differential effects on tests of attention and learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Atomoxetine produces changes in cortico-basal thalamic loop circuits: assessed by phMRI BOLD contrast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Prospective association between emotional health and clinical evidence of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Cueing method biases in visual detection studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

The impact of deep brain stimulation on executive function in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Atomoxetine for freezing of gait in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Switching between abstract rules reflects disease severity but not dopaminergic status in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Effects of methylphenidate, desipramine, and l-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Methylphenidate effects on prefrontal functioning during attentional-capture and response inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Failed suppression of direct visuomotor activation in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

The control of deliberate waiting strategies in a stop-signal task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Stimulation of the subthalamic region facilitates the selection and inhibition of motor responses in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Reliability and plasticity of response inhibition and interference control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

A neurodevelopmental view of impulsivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Mixing pro- and antisaccades in patients with parkinsonian syndromes.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Compulsive buying: descriptive characteristics and psychiatric comorbidity.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

In a rat model of parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4065022

Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease

30 October 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU117

Determination of atomoxetine in human plasma by a high performance liquid chromatographic method with ultraviolet detection using liquid-liquid extraction

21 January 2018

1 reference

12 December 2020

Levodopa medication does not influence motor inhibition or conflict resolution in a conditional stop-signal task in Parkinson's disease

1 reference

12 December 2020

The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport

1 reference

12 December 2020

Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleus

1 reference

12 December 2020

Identifiers

DOI

10.1093/BRAIN/AWU117

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

PubMed ID

24893708